Tenax Therapeutics
Phase 3 AI-extracted
TNX-103
PH-HFpEF
Countdown
54days
Phase 3 readout Β· Aug 29, 2026
What's at stake Phase 3 trial results for TNX-103 in PH-HFpEF are due Aug 29, 2026. A clean hit validates the program; a miss can gap the stock down hard.
β€œThe Company now expects to report data in August 2026, and in the weeks ahead will proceed towards the planned database lock and statistical analysis.”

Provenance

4 sources on file.

Link copied βœ“